| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |